B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole.
作者信息
Mielants H, Veys E M
出版信息
Acta Rhumatol Belg. 1979 Apr-Jun;3(2):104-9.
PMID:546061
Abstract
摘要
相似文献
1
B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole.
Acta Rhumatol Belg. 1979 Apr-Jun;3(2):104-9.
2
A study of the hematological side effects of levamisole in rheumatoid arthritis with recommendations.
J Rheumatol Suppl. 1978;4:77-83.
3
B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole.
Acta Rhumatol. 1979 Apr-Jun;3(2):104-7; discussion 107-9.
4
Agranulocytosis, levamisole, and HLA-B27.
Lancet. 1977 Oct 8;2(8041):764. doi: 10.1016/s0140-6736(77)90270-7.
5
Agranulocytosis, levamisole, and HLA-B27.
Lancet. 1977 Jul 9;2(8028):85. doi: 10.1016/s0140-6736(77)90082-4.
6
[Letter: Agranulocytosis during rheumatoid arthritis treated by levamisole].
Nouv Presse Med. 1976 May 1;5(18):1212.
7
HLA-B27, antinuclear antibodies and drug-induced agranulocytosis.
Klin Wochenschr. 1978 Dec 1;56(23):1189-91. doi: 10.1007/BF01476864.
8
Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies.
Int Arch Allergy Appl Immunol. 1981;65(4):460-4. doi: 10.1159/000232788.
9
[Agranulocytosis in patients with rheumatoid arthritis treated with levamisole--mechanism and prevention].
Przegl Lek. 1982;39(9):613-6.
10
Adverse reactions to levamisole.
Cancer Treat Rep. 1978 Nov;62(11):1721-30.
Zotero 插件